Medigus Stock Analysis

MDGS
 Stock
  

USD 6.17  0.17  2.68%   

The big decline in price over the last few months for Medigus Ltd ADRmay encourage retail investors to take a closer look at the firm as it is trading at a share price of 6.17 on 13,246 in trading volume. The company executives failed to add value to investors and position the firm supply of money to exploit market volatility in November. However, diversifying your holdings with Medigus or similar stocks can still protect your portfolios during high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 4.99. This high volatility is attributed to the latest market swings and not-so-good earnings reports for some of the Medigus Ltd ADR partners.
Additionally, see Correlation Analysis.
  
The Medigus stock analysis report makes it easy to digest most publicly released information about Medigus and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Medigus Stock analysis module also helps to analyze the Medigus price relationship with some important fundamental indicators such as market cap and management efficiency.

Medigus Stock Analysis Notes

The company has price-to-book ratio of 0.26. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Medigus Ltd ADR last dividend was issued on the 16th of July 2018. The entity had 1:15 split on the 14th of November 2022. Medigus Ltd., a technology-based company, provides medical-related devices and products in the United States, Europe, China, Israel, and internationally. Medigus Ltd. was incorporated in 1999 and is headquartered in Tel Aviv-Yafo, Israel. Medigus operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 26 people. To find out more about Medigus Ltd ADR contact Christopher Rowland at 972 73 370 4691 or learn more at https://www.medigus.com.

Medigus Ltd ADR Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Medigus' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Medigus Ltd ADR or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Medigus Ltd ADR generated a negative expected return over the last 90 days
Medigus Ltd ADR has high historical volatility and very poor performance
Medigus Ltd ADR currently holds about 24.75 M in cash with (5.25 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.01.

Medigus SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Medigus prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Medigus investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Medigus Ltd ADR specific information freely available to individual and institutional investors to make a timely investment decision.

Medigus Market Capitalization

The company currently falls under 'Micro-Cap' category with current market capitalization of 10.87 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Medigus's market, we take the total number of its shares issued and multiply it by Medigus's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Medigus Profitablity

Medigus' profitability indicators refer to fundamental financial ratios that showcase Medigus' ability to generate income relative to its revenue or operating costs. If, let's say, Medigus is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Medigus' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Medigus' profitability requires more research than a typical breakdown of Medigus' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (0.15) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.15) %, which suggests for every $100 dollars of sales, it generated a net operating loss of 0.0.

Management Efficiency

The entity has return on total asset (ROA) of (0.0523) % which means that it has lost $0.0523 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (0.1612) %, meaning that it created substantial loss on money invested by shareholders. Medigus management efficiency ratios could be used to measure how well medigus ltd adr manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 1st of December, Medigus secures the mean deviation of 3.02, and Risk Adjusted Performance of (0.16). In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Medigus Ltd ADR, as well as the relationship between them. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We were able to analyze and collect data for nineteen technical drivers for Medigus, which can be compared to its peers in the industry. Please verify Medigus Ltd ADR variance, as well as the relationship between the value at risk and skewness to decide if Medigus Ltd ADR is priced some-what accurately, providing market reflects its recent price of 6.17 per share. Given that Medigus Ltd ADR has jensen alpha of (0.51), we recommend you to check Medigus's last-minute market performance to make sure the company can sustain itself at a future point.

Medigus Ltd ADR Price Movement Analysis

The output start index for this execution was thirty-three with a total number of output elements of twenty-eight. Medigus Ltd ADR Triple Exponential Moving Average indicator shows smoothing effect of Medigus price series composite of a single exponential moving average, a double exponential moving average and a triple exponential moving average.
.

Medigus Predictive Daily Indicators

Medigus intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Medigus stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Medigus Forecast Models

Medigus time-series forecasting models is one of many Medigus' stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Medigus' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Medigus Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Medigus prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Medigus shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual Stock such as Medigus. By using and applying Medigus Stock analysis, traders can create a robust methodology for identifying Medigus entry and exit points for their positions.
Medigus Ltd., a technology-based company, provides medical-related devices and products in the United States, Europe, China, Israel, and internationally. Medigus Ltd. was incorporated in 1999 and is headquartered in Tel Aviv-Yafo, Israel. Medigus operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 26 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Medigus to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Positions Ratings Now

   

Positions Ratings

Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
All  Next Launch Module
Additionally, see Correlation Analysis. Note that the Medigus Ltd ADR information on this page should be used as a complementary analysis to other Medigus' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Analyst Recommendations module to analyst recommendations and target price estimates broken down by several categories.

Complementary Tools for Medigus Stock analysis

When running Medigus Ltd ADR price analysis, check to measure Medigus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medigus is operating at the current time. Most of Medigus' value examination focuses on studying past and present price action to predict the probability of Medigus' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Medigus' price. Additionally, you may evaluate how the addition of Medigus to your portfolios can decrease your overall portfolio volatility.
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Is Medigus' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Medigus. If investors know Medigus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Medigus listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
10.9 M
Quarterly Revenue Growth YOY
13.61
Return On Assets
(0.05) 
Return On Equity
(0.16) 
The market value of Medigus Ltd ADR is measured differently than its book value, which is the value of Medigus that is recorded on the company's balance sheet. Investors also form their own opinion of Medigus' value that differs from its market value or its book value, called intrinsic value, which is Medigus' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Medigus' market value can be influenced by many factors that don't directly affect Medigus' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Medigus' value and its price as these two are different measures arrived at by different means. Investors typically determine Medigus value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medigus' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.